Menu
Your Cart

Clinical Trials Covid-19 RSS Feed

Research teams are testing the effectiveness of Artemisia annua against Covid-19, mainly in the United States, but also in Europe and South Africa. Several Chinese studies had shown in 2003 that this plant, traditionally used against malaria, had strong antiviral activity against SARS-Cov-2.

08 Sep2021 ARTEMISIA PREVENT SARS-CoV-2 REPLICATION IN VITRO
0 413
Artemisia plant extract prevents SARS-CoV-2 replication in vitro The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), which is the virus responsible for the coronavirus disease 2019 (COVID-19), was originally detected in Wuhan,..
23 Aug2021 INHIBITORS OF SARS-COV-2 FROM ARTEMISIA ANNUA - NIGERIA
0 474
A group of researchers in Biochemistry from several universities in Nigeria have just published a study which demonstrates significant activity of Artemisia annua against the severe acute respiratory syndrome coronavirus (SARS-CoV) and the ..
21 Jul2021 ARTEMISIA ACTIVE AGAINST SARS-CoV-2
0 385
Denmark, Germany and Hong Kong.Extracts from artemisia annua plant found to be active against SARS-CoV-2 virus under laboratory conditionsA team of researchers affiliated with institutions in Denmark, Germany and Hong Kong has found that se..
18 Jul2021 CLINICAL TRIALS IN AMERICA
Michael 0 273
University of Kentucky, USA  “Researchers at the Faculty of Medicine launched a clinical trial to verify the plant's effectiveness against COVID-19. A 2005 Chinese study showed that Artemisia annua had strong antiviral activity against SRAS..
18 Jul2021 CLINICAL TRIALS IN MEXICO
Michael 0 220
National Institute of Medical Sciences and Nutrition Salvador Zubirán, Mexico Launch of a large clinical trial in 360 Covid-19 patients with comorbidities (diabetes, obesity, hypertension, etc.) in September 2020. The aim of the clinical tr..
16 Jul2021 ARTEMÍSIA EFFECTIVE AGAINST SARS-CoV-2
0 344
Artemisia annua effective against SARS-Cov-2 A global coalition of researchers has found that extracts from Artemisia annua can inhibit the replication of SARS-CoV-2 in a laboratory. Publishing in Scientific Reports they report on three dif..
04 May2021 ARTEMISIA INHIBITES COVID-19
0 284
Researchers in the United States have shown that extracts of an aromatic herb called Artemisia annua inhibit the replication of severe acute respiratory coronavirus (SARS-CoV-2) – the agent responsible for the current coronavirus disease 20..
01 Mar2021 CLINICAL TRIALS IN INDIA
0 200
India Artemisia annua L. extracts inhibit the in vitro replication of SARS-CoV-2 and two of its variants.Artemisia research for COVID-19 suggests its ability to inhibit and prevent virus replication. Lung diseases like COVID cause respirato..
07 Oct2020 CLINICAL TRIALS IN CROATIA
0 197
October 7, 2020 - Medical professionals remain cautious, but German media reports that scientists in their country have evidence to suggest that sweet wormwood is effective in treating COVID-19. Known as Slatki Pelin in Croatia, the plant i..
10 Jul2020 CLINICAL TRIALS IN SOUTH AFRICA
0 272
STATUS OF CLINICAL TRIALS South AfricaNorthwestern University, South Africa"We are raising funds to scientifically investigate the potential to develop Mugwort into an effective treatment of COVID 19. All funds will be administered by North..
24 Jun2020 CLINICAL TRIALS IN EUROPE
0 335
STATUS OF CLINICAL TRIALSEurope Max Planck Institute and Free University of Berlin (Germany) and University of Copenhagen (Denmark)Effective and affordable treatments are needed for COVID-19 patients. We report the in vitro efficacy of Arte..
Showing 1 to 11 of 11 (1 Pages)